Don founded Translational Software® to accelerate the use of molecular diagnostics. Prior to this he had a 14 year career at Microsoft, holding a variety of roles in providing Internet access to MSN, pioneering Virtual Private Networking products, and integrating Instant Messaging with Voice Over IP networks. Don founded the BioIT Alliance from within Microsoft to accelerate collaboration in translational research.
By the end of 2018, more than 26 million consumers had undergone direct-to-consumer (DTC) genetic testing. These genetic tests promise to identify medically relevant genetic variants, identify a consumer’s genetic
A growing body of evidence has linked pharmacogenomic (PGx) testing to better patient outcomes, lower healthcare costs, reduced hospital readmission rates, and prevented adverse drug reactions. Change often comes to
Pharmacogenomics (PGx) has the power to revolutionize health care, save lives, reduce side effects, improve care outcomes, and save money. Illnesses like depression, which have high relapse rates and even higher
Pharmacogenomic (PGx) testing allows healthcare providers to make more informed, evidence-based decisions for their patients. To take advantage of this new clinical tool, we’ve recently seen several large